// App-Quantinova.ai

OR5‐025 : Oral anticoagulant agent‐associated bleeding events reporting system (ORANGE) study

Researchers

Presenter

  • L Green

Principal Investigators

  • J Tan

  • R Alikhan

  • N Curry

  • T Everington

  • R Maclean

  • K Saja

  • S Stanworth

  • C Tait

  • J Morris

  • P MacCallum

Medical Centers

  • Barts Health NHS Trust

  • NHS Blood and Transplant

  • Blizard Institute

  • Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom

  • University Hospital of Wales, Cardiff, AK

  • Oxford University Hospitals NHS Trust, Oxford,

  • Hampshire Hospitals NHS Foundation Trust, Basingstoke

  • Salisbury NHS Foundation Trust, Salisbury

  • Sheffield Teaching Hospitals NHS Foundation Trust

  • Barking, Havering and Redbridge University Hospitals NHS Trust, London, UK

  • NHS blood and Transplant, Oxford, UK

  • Glasgow Royal Infirmary, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • Collagen type IV alpha 2 chain

Drug/Treatment

  • Prothrombin complex

  • Tranexamic acid

  • Caprilon

  • rivaroxaban

  • Pradax

  • apixaban

  • Edoxaban

  • Warfarin

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved